Seeing Is Believing
Currently out of the existing stock ratings of Tazeen Ahmad, 148 are a BUY (59.44%), 67 are a HOLD (26.91%), 34 are a SELL (13.65%).
Analyst Tazeen Ahmad, currently employed at BAML, carries an average stock price target met ratio of 49.97% that have a potential upside of 26.85% achieved within 137 days.
Tazeen Ahmad’s has documented 500 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on RYTM, Rhythm Pharmaceuticals at 10-Apr-2025.
Analyst best performing recommendations are on SRZN (SURROZEN).
The best stock recommendation documented was for SRZN (SURROZEN) at 11/17/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.65 (9.91%) receiving and performance score of 99.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$28
$13.27 (90.09%)
$28
16 days ago
(08-Apr-2025)
0/7 (0%)
$13.9 (98.58%)
Hold
$20
$5.27 (35.78%)
$20
1 months 17 days ago
(07-Mar-2025)
16/21 (76.19%)
$2.39 (13.57%)
172
Buy
$27
$12.27 (83.30%)
$27
1 months 28 days ago
(27-Feb-2025)
7/21 (33.33%)
$7.66 (39.61%)
118
Buy
$28
$13.27 (90.09%)
$28
1 months 28 days ago
(27-Feb-2025)
25/37 (67.57%)
$8.66 (44.78%)
486
Hold
$22
$7.27 (49.36%)
$24
2 months 13 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Which stock is Tazeen Ahmad is most bullish on?
Which stock is Tazeen Ahmad is most reserved on?
What Year was the first public recommendation made by Tazeen Ahmad?